Study identifies and addresses US cancer screening deficits due to the COVID-19 pandemic

Deaths from cancer are expected to increase over the next decade as a result of screening deficits due to the COVID-19 pandemic. New research published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, reveals the extent of screening deficits in breast, colorectal, lung, and cervical cancers across the United States and describes the efforts that clinics are making to address missed screenings.

In the study, which was initiated by the American College of Surgeons Cancer Programs and the American Cancer Society, 748 accredited cancer programs in the United States were enrolled from April 2021 through June 2021. Most facilities reported monthly screening deficits: the percentages reporting deficits for colorectal, cervical, breast, and lung cancer screening were 80.6%, 69.0%, 55.3%, and 44.6%, respectively. Geographic differences were not observed based on where the cancer programs were located across the United States.

Using these results, the participating accredited cancer programs initiated a total of 814 quality improvement projects to address various barriers to screening. The effects of these interventions on screening rates through 2021 are being assessed, but the estimated numbers of potential additional monthly screening tests if all participating facilities reach their target goals are 57,141 for breast cancer, 6,079 for colorectal cancer, 4,280 for cervical cancer, and 1,744 for lung cancer.

“From the perspective of people’s health, we are hopeful that this collaborative effort between the American College of Surgeons Cancer Programs and the American Cancer Society may have saved many patients from unnecessary suffering and death from cancer,” said corresponding author Heidi Nelson, MD, FACS, Medical Director of Cancer Programs at the American College of Surgeons. “From the perspective of what this means about our programs, we now know that we can turn to our accredited programs in times of crisis to help address large-scale cancer problems. Knowing how enthusiastic these accredited programs are for working collaboratively on national level problems, we expect to release one or two quality improvement projects each year going forward.”

The study is especially timely given that the American Cancer Society's National Consortium for Cancer Screening and Care recently announced nine consensus recommendations to accelerate recovery from the pandemic and improve the nation's ability to provide quality cancer screening and care for all.

March is Colorectal Cancer Awareness Month. The American Cancer Society recommends colorectal screening beginning at age 45 for individuals at average risk for the disease.

Additional Information

NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the Cancer News Room upon online publication. For more information or to obtain a PDF of any study, please contact:

Dawn Peters +1 781-388-8408 (US)
newsroom@wiley.com
Follow us on Twitter @WileyNews

Full Citation:

“A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.” Rachel H. Joung, Heidi Nelson, Timothy W. Mullett, Scott H. Kurtzman, Sarah Shafir, James B. Harris, Katharine A. Yao, Brian C. Brajcich, Karl Y. Bilimoria, and William G. Cance. CANCER; Published Online: March 21, 2022 (DOI: 10.1002/cncr.34157).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.34157

Author Contact: Sally Garneski, of the American College of Surgeons Integrated Communications team, at pressinquiry@facs.org or +1 312-202-5409.

About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online.

Follow us on Twitter @JournalCancer

About Wiley

Wiley is a global leader in research and education, unlocking human potential by enabling discovery, powering education, and shaping workforces. For over 200 years, Wiley has fueled the world’s knowledge ecosystem. Today, our high-impact content, platforms, and services help researchers, learners, institutions, and corporations achieve their goals in an ever-changing world. Visit us at  Wiley.com, like us on Facebook and follow us on Twitter and LinkedIn.